Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT00763035
Eligibility Criteria:
Inclusion Criteria:
* Men and women aged 40 to 85 years with OBSTRUCTIVE AIRWAY DISEASES (ASTHMA AND COPD) and a forced expiratory volume (FEV1) \> 0.5.
* Patients should have a clinical indication to undergo cardiac stress test with dobutamine.
Exclusion Criteria:
* Those with pacemakers, defibrillators, functioning neural stimulator devices or other implanted electronic devices.
* Ferromagnetic cerebral aneurism clips or other intraorbital and intracranial metal.
* An allergy to Gadolinium or other severe drug allergies.
* Acute myocardial infarction within 3 months.
* Moderate or severe aortic stenosis or other significant valvular disease;
* Claustrophobia.
* High grade (2o or 3o) AV Block.
* Closed angle glaucoma.
* Participants unable to provide informed consent.
* Renal dialysis (subjects with moderate-to-severe renal impairment defined as eGFR \< 60 mL/min.
* A contraindication to receipt of dobutamine.
* Participants with known coronary artery disease will be included with the exception that patients with left main or narrowings \>50% in the distributions of the left anterior descending, circumflex, and right coronary artery will be excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT00763035
Study Brief:
Protocol Section:
NCT00763035